http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101049858-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-701 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0602 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 |
| filingDate | 2008-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101049858-B1 |
| titleOfInvention | HIV-1 latent cell lines, methods for their preparation and diagnostic methods for latent HIV infection |
| abstract | The present invention relates to a latent HIV-infected cell line, a method for preparing the same, and a method for diagnosing latent HIV infection. ) Latent HIV-infected cell line NCHA-3 characterized in that the gene is fused. For this reason, the latent HIV-infected cell lines of the present invention contain HIV proviruses and exhibit molecular molecular characteristics different from those of conventional latent cell lines, which are useful for studies on the latent nature and reactivation of HIV proviruses. Furthermore, by effectively identifying the latent pathology of HIV, it can ultimately contribute to the treatment and prevention of AIDS in HIV / AIDS patients.n n n n Cell line, HIV-1, latent infection, decreased receptor expression, histone H3 modification |
| priorityDate | 2008-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 159.